Scaling-up a fragment-based protein-protein interaction method using a human reference interaction set.

Area of Science:

• Molecular Biology
• Biochemistry
• Genomics

Background:

• Protein-protein interactions (PPIs) are fundamental to cellular processes and protein function.
• Understanding PPIs is crucial for deciphering complex biological pathways and disease mechanisms.
• The all-vs-all sequencing (AVA-Seq) approach offers a scalable method for PPI discovery.

Purpose of the Study:

• To scale and modify the AVA-Seq method for enhanced PPI detection.
• To optimize AVA-Seq analysis parameters using a gold-standard human protein interaction set (hsPRS-v2).
• To adapt standard sequencing analysis for large-scale interaction studies.

Main Methods:

• Applied and modified the AVA-Seq approach to a human protein interaction set (hsPRS-v2).
• Optimized data scaling, auto-activator removal, feature ranking, and statistical cutoffs.
• Validated the modified AVA-Seq method for genome-wide PPI studies.

Main Results:

• The optimized AVA-Seq method recovered 43% of known binary PPIs from the hsPRS-v2.
• Significant modifications were required to handle the increased interaction search space.
• The enhanced AVA-Seq identified over 500 known and novel PPIs, including interactions involving tumor protein p53 and MCM2/MCM5.

Conclusions:

• The modified AVA-Seq method is effective for large-scale PPI discovery.
• Optimized AVA-Seq analysis enables the identification of thousands of PPIs in a single run.
• The identified PPIs, such as those involving p53 and MCM proteins, may have implications for human disease research.